Browsing by Author Punee Pitisuttithum

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
1-Jun-2006Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and CameroonSwati B. Gupta; Christopher T. Mast; Nathan D. Wolfe; Vlad Novitsky; Sheri A. Dubey; Esper G. Kallas; Mauro Schechter; Bernard Mbewe; Eftyhia Vardas; Punee Pitisuttithum; Donald Burke; Dan Freed; Robin Mogg; Paul M. Coplan; Jon H. Condra; Romnie S. Long; Kiersten Anderson; Danilo R. Casimiro; John W. Shiver; Walter L. Straus; Merck & Co., Inc.; Johns Hopkins Bloomberg School of Public Health; Harvard School of Public Health; Universidade Federal de Sao Paulo; Universidade Federal do Rio de Janeiro; Malawi College of Medicine; Ministry of Population and Health; University of Witwatersrand; Mahidol University; Intl. Partnership for Microbicides; Merck Research Laboratories
22-Jan-2010International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trialsT. Christopher Mast; Lisa Kierstead; Swati B. Gupta; Alexander A. Nikas; Esper G. Kallas; Vladimir Novitsky; Bernard Mbewe; Punee Pitisuttithum; Mauro Schechter; Eftyhia Vardas; Nathan D. Wolfe; Miguel Aste-Amezaga; Danilo R. Casimiro; Paul Coplan; Walter L. Straus; John W. Shiver; Merck Research Laboratories; Universidade Federal de Sao Paulo; Harvard School of Public Health; Malawi College of Medicine; Mahidol University; Universidade Federal do Rio; University of Witwatersrand; Johns Hopkins Bloomberg School of Public Health
1-Jun-2012Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccineKatie Matys; Sara Mallary; Oliver Bautista; Scott Vuocolo; Ricardo Manalastas; Punee Pitisuttithum; Alfred Saah; MRL; Merck & Co., Inc.; Philippine General Hospital; Mahidol University; PPD Vaccine and Biologics
20-Aug-2014Placebo use in vaccine trials: Recommendations of a WHO expert panelAnnette Rid; Abha Saxena; Abdhullah H. Baqui; Anant Bhan; Julie Bines; Marie Charlotte Bouesseau; Arthur Caplan; James Colgrove; Ames Dhai; Rita Gomez-Diaz; Shane K. Green; Gagandeep Kang; Rosanna Lagos; Patricia Loh; Alex John London; Kim Mulholland; Pieter Neels; Punee Pitisuttithum; Samba Cor Sarr; Michael Selgelid; Mark Sheehan; Peter G. Smith; King's College London; Organisation Mondiale de la Sante; Johns Hopkins Bloomberg School of Public Health; University of Toronto; University of Melbourne; NYU School of Medicine; Columbia University Medical Center; University of the Witwatersrand, Faculty of Health Sciences; Instituto Mexicano del Seguro Social; Saint Michael's Hospital University of Toronto; Christian Medical College, Vellore; Hospital de Ninos Robeto del Rio; Melbourne Law School; Carnegie Mellon University; London School of Hygiene & Tropical Medicine; Vaccine Advice BVBA; Mahidol University; Ministry of Health and Social Action 1; Monash University; University of Oxford
5-Jun-2009Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trialNubia Muñoz; Ricardo Manalastas; Punee Pitisuttithum; Damrong Tresukosol; Joseph Monsonego; Kevin Ault; Christine Clavel; Joaquin Luna; Evan Myers; Sara Hood; Oliver Bautista; Janine Bryan; Frank J. Taddeo; Mark T. Esser; Scott Vuocolo; Richard M. Haupt; Eliav Barr; Alfred Saah; National Cancer Institute; Philippine General Hospital; Mahidol University; King Chulalongkorn Memorial Hospital, Faculty of Medicine Chulalongkorn University; Federation Mutualiste Parisienne; Emory University School of Medicine; CHU de Reims; Duke University School of Medicine; Merck & Co., Inc.